HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

17-Hydroxyprogesterone

HCID 6238
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
110850-01-6
Standard SMILES
CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C
InChIKey
DBPWSSGDRRHUNT-CEGNMAFCSA-N
Molecular formula
C21H30O3
Average molar mass
330.5 g/mol

Overview

17alpha-hydroxyprogesterone is a 17alpha-hydroxy steroid that is the 17alpha-hydroxy derivative of progesterone. It has a role as a metabolite, a progestin, a mouse metabolite and a human metabolite. It is a 17alpha-hydroxy-C21-steroid, a tertiary alpha-hydroxy ketone and a 17alpha-hydroxy steroid. It is functionally related to a progesterone.

Names & identifiers

Preferred name
17-Hydroxyprogesterone
IUPAC
(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
English name
17α-Hydroxyprogesterone
Molecular formula
C21H30O3
Molecular weight
330.46

Names & synonyms

hydroxyprogesterone68-96-217ALPHA-HYDROXYPROGESTERONE17-HydroxyprogesteroneProdixProdoxGestageno gador17-alpha-Hydroxyprogesterone17-Hydroxypregn-4-ene-3,20-dioneGestagenoHidroxiprogesteronaHydroxyprogesteronum
Show more names
17A-HYDROXYPROGESTERONE17α-Hydroxyprogesterone17-OHPHYDROXYPROGESTERONE, 17A-U 3096
17alpha-Hydroxy-4-pregnene-3,20-dione17-OH Progesteronedelta(4)-Pregnene-17alpha-ol-3,20-dione17alpha-Hydroxy-progesteronePregn-4-ene-3,20-dione-17-olIdrossiprogesteronealpha Hydroxy progesteroneDTXSID6040747

Database identifiers

CAS
110850-01-6、68-96-2
PubChem CID
6238
DTXSID
DTXSID00859075
ChEMBL
CHEMBL1062
ChEBI
CHEBI:17252

Properties

Computed structural propertiesFilling in

XLogP
3.2
Topological polar surface area
54.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
1
Heavy atoms
24
Formal charge
0
Complexity
635

Experimental & physicochemical properties

LipidsLipids -> Sterol Lipids [ST] -> Steroids [ST02] -> C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives [ST0203]
SpringerMaterials PropertiesChemical shift
LogP3.17
Color/FormRHOMBIC OR HEXAGONAL LEAFLETS FROM ACETONE OR ALCOHOL
Solubility0.00648 mg/mL
Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Endocrine DisruptorsPotential endocrine disrupting compound
Melting Point · 2 items

222-223 °C

219 - 220 °C

Optical RotationSPECIFIC OPTICAL ROTATION (CHLOROFORM, 1.0417%): +105.6 DEG @ 17 °C/D
Physical Description

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H360 (95.1%): May damage fertility or the unborn child [Danger Reproductive toxicity]

P203, P280, P318, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory Information · 2 items

Status: Active Update: 28-07-2021 https://echa.europa.eu/registration-dossier/-/registered-dossier/20280

Hydroxyprogesterone: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Other Safety InformationIMAP assessments - Pregn-4-ene-3,20-dione, 17-hydroxy-: Environment tier I assessment
Hazard Classes and CategoriesRepr. 1B (95.1%)

Toxicology

Interactions...ESTROGEN ENHANCED SUPPRESSIVE EFFECT OF PROGESTIN & LED TO GENERAL USE OF MIXTURE OF TWO. /PROGESTINS/
Human Toxicity Excerpts · 5 items

...MAY CAUSE EDEMA & LOCAL REACTIONS @ SITE OF INJECTION.

MOST COMMON EFFECTS ARE NAUSEA, EDEMA, & IRREGULAR VAGINAL BLEEDING. OTHER REPORTED EFFECTS INCL WT GAIN, DECR LIBIDO, DEPRESSION, JAUNDICE, & CONGESTIVE HEART FAILURE. /CAPROATE/

...HYDROXYPROGESTERONE CAPROATE OCCASIONALLY CAUSES HYPERSENSITIVITY, COUGHING, OR DYSPNEA. IN RARE INSTANCES IT MAY CAUSE VIRILIZATION OF FEMALE FETUS. /CAPROATE/

Chemistry & industry

Pharmacology

ATC Code · 2 items

G - Genito urinary system and sex hormones

QG - Genito urinary system and sex hormones

Mechanism of Action · 2 items

ADMIN OF ESTROGEN & PROGESTIN, AS CONTAINED IN COMBINATION OR SEQUENTIAL PREPN, COULD INTERFERE WITH FERTILITY IN ANY ONE OF SEVERAL WAYS. HOWEVER, IT IS CLEAR THAT, AS CURRENTLY USED, MIXTURE INHIBITS OVULATION. ...CONTINUED ACTION OF PROGESTERONE SERVES TO INHIBIT RELEASE OF LH. /PROGESTINS/

IT ACTS AS ANTIGONADOTROPHIC AGENT ON ANTERIOR PITUITARY INHIBITING FSH RELEASE &, THUS, FOLLICULAR GROWTH, ESTROGEN PRODUCTION, & ESTRUS. IT ALSO INHIBITS LH RELEASE, THUS PREVENTING OVULATION, CORPORA LUTEA FORMATION, & FURTHER PROGESTERONE SECRETION. BY INHIBITING LH...HOLDS PROGESTERONE LEVELS IN CHECK.

Metabolism/Metabolites17alpha-hydroxy-progesterone has known human metabolites that include 17Beta-21-dihydroxyprogesterone.
FDA Pharmacological Classification · 5 items

21807M87J2

HYDROXYPROGESTERONE

Chemical Structure [CS] - Progesterone Congeners

Established Pharmacologic Class [EPC] - Progestin

Hydroxyprogesterone is a Progestin.

Absorption, Distribution and Excretion · 3 items

...DURATION OF ACTION IS LONGER /THAN PROGESTERONE/, BUT ITS ONSET OF ACTION IS SLOWER. SINGLE INJECTION OF SOLN OF HYDROXYPROGESTERONE CAPROATE IN OIL WILL EXERT PROGESTATIONAL EFFECTS FOR 1-2 WK. /CAPROATE/

ABOUT 50-60% OF ADMIN RADIOACTIVE PROGESTERONE APPEARS IN URINE & ABOUT 10% IN FECES. ... WHEN PROGESTERONE IS GIVEN FOR PROLONGED PERIOD, DURING LUTEAL PHASE OF CYCLE, OR DURING PREGNANCY, LARGER PROPORTION (25-30%) APPEARS IN URINE AS PREGUANEDIOL. /PROGESTERONE/

RATE OF TURNOVER OF ENDOGENOUS PROGESTERONE IS UNUSUALLY RAPID, T/2 IN BLOOD BEING FEW MIN, & DOUBTLESS EXOGENOUS MATERIAL IS HANDLED IN SAME WAY. SMALL AMT...IS STORED IN BODY FAT... PRESUMABLY, ABSORPTION FROM INTESTINAL TRACT IS PROMPT, BUT COMPD IS RAPIDLY TRANSFORMED DURING PASSAGE THROUGH LIVER... /PROGESTERONE/

Related reactions

6 records
New reaction record
HRID 433655 reaction equation
HRID 433655As product
HRID 1065207 reaction equation
HRID 1065207As reactant
HRID 1164192 reaction equation
HRID 1164192As product
HRID 1447579 reaction equation
HRID 1447579As reactant
HRID 1979672 reaction equation
HRID 1979672As product
HRID 2059164 reaction equation
HRID 2059164As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
UNII
21807M87J2
EC Number
200-699-4
Nikkaji
J4.862C
Solid
Stability/Shelf LifeCRYSTALS SHOULD NOT BE EXPOSED TO HEAT & LIGHT /CAPROATE/
Collision Cross Section · 6 items

184.4 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID6040747]

183.4 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

187.57 Ų [M+H]+ [CCS Type: DT; Method: stepped-field]

179.9 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

202.46 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

187 Ų [M-H]-

Physicochemical properties

Melting point
276 °C · 276°C
Boiling point
407.89 °C · 407.89°C (rough estimate)
Density
1.0998 · 1.0998 (rough estimate)
refractive index
90 ° · 90 ° (C=1, CHCl3)
Flash point
9 ℃ · 9℃
storage temp.
Sealed in dry,Room Temperature
solubility
soluble in Chloroform
pka
13.03 · 13.03±0.60(Predicted)
form
Solid
color
White to Almost white
Water Solubility
5.056 mg/L · 5.056mg/L(20 ºC)
Merck
14 · 14,4839
BRN
3218109 · 3218109
Major Application
pharmaceutical small molecule
CAS DataBase Reference
68 · 68-96-2(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
21807 M87J2 · 21807M87J2
ATC code
3 DA03 · G03DA03
NIST Chemistry Reference
-4 · Pregn-4-ene-3,20-dione, 17-hydroxy-(68-96-2)
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
8 · GHS08,GHS09
Signal word
Danger
Hazard statements
360 FD-H411 · H360FD-H411
Precautionary statements
202 · P202-P273-P280-P308+P313-P391-P405
Hazard Codes
T,F
Risk Statements
61 · 61-39/23/24/25-23/24/25-11
Safety Statements
53 · 53-22-36/37/39-45-36/37-16
RIDADR
1230 · UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany
3 · 3
RTECS
5060000 · TU5060000
HS Code
38220090 · 38220090
Hazardous Substances Data
68 · 68-96-2(Hazardous Substances Data)
REACH Registrations
Active

CONTINUOUS ADMIN OF PROGESTIN IN SUFFICIENT DOSE ABOLISHES CYCLE FOR AS LONG AS IT IS GIVEN & LEADS TO OVARIAN & ENDOMETRIAL ATROPHY. VERY SMALL DOSES MAY ALTER STRUCTURE OF ENDOMETRIUM & CONSISTENCY OF CERVICAL MUCUS WITHOUT DISRUPTING CYCLE OR INHIBITING OVULATION. /PROGESTINS/

For more Human Toxicity Excerpts (Complete) data for 17ALPHA-HYDROXYPROGESTERONE (10 total), please visit the HSDB record page.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Non-Human Toxicity Excerpts · 2 items

NO VIRILIZING EFFECTS WERE OBSERVED IN DBA MICE GIVEN DAILY SC INJECTIONS OF 0.25 MG 17ALPHA-HYDROXYPROGESTERONE CAPROATE ON DAYS 16-19 OF GESTATION OR IN SPRAGUE-DAWLEY RATS GIVEN 5 MG DAILY FROM DAY 14-19 OF GESTATION. /CAPROATE/

OF 19 YOUNG, RANDOM-BRED FEMALE RABBITS INJECTED IM WITH 13 MG...IN SESAME OIL ON ALTERNATE WK FOR UP TO 109 WK, 14 DEVELOPED...CYSTS OF ENDOMETRIUM DURING 1ST 267 DAYS. IN 7/8 ANIMALS...ALIVE @ 109 WK, CYSTS WERE UNILOCULAR... IN CONTROL...FEW CYSTS...LESS THAN 0.3 MM IN DIAM...SMALL NON-NEOPLASTIC POLYPS... /CAPROATE/

Safety data

wgk
3
rtecs
TU5060000
ridadr
UN1230 - class 3 - PG 2 - Methanol, solution
hs_code
38220090
risk_code
61-39/23/24/25-23/24/25-11
Signal word
Danger
Symbol(GHS)
GHS08,GHS09
hazard_code
T,F
safety_code
53-22-36/37/39-45-36/37-16
Hazard statements
H360FD-H411
REACH Registrations
Active
Precautionary statements
P202-P273-P280-P308+P313-P391-P405
Hazardous Substances Data
68-96-2(Hazardous Substances Data)
Tissue Locations
Adipose Tissue
Cellular LocationsCytoplasm
Metabolite Pathways11-beta-hydroxylase deficiency (CYP11B1)

Uses & manufacturing

Uses · 4 items

MEDICATION (VET)

MEDICATION

Use (kg; approx.) in Germany (2009): >25

This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.

Methods of Manufacturing · 2 items

HYDROXYPROGESTERONE IS ESTERIFIED BY HEATING WITH CAPROIC ANHYDRIDE IN PRESENCE OF P-TOLUENE-SULFONIC ACID UNDER ATMOSPHERE OF NITROGEN. US PATENT 2,753,360. /CAPROATE/

JULIAN ET AL, US PATENT 2,648,662 (1953 TO GLIDDEN)...STORK ET AL, US PATENTS 2,802,839 & 2,805,203 (BOTH 1957 TO SYNTEX)...DULANEY, MCALEER; US PATENTS 2,777,843; 2,786,856/7; 2,813,060 (ALL 1957 TO MERCK & CO)...PEDERSON, US PATENT 3,000,883 (1961 TO UPJOHN).

Formulations/PreparationsHYDROXYPROGESTERONE CAPROATE INJECTION, USP (DELALUTIN), IS PROVIDED AS OILY SOLN OF 125 MG/ML (IN SESAME OIL) OR 250 MG/ML (IN CASTOR OIL) FOR IM INJECTION. /CAPROATE/
Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
General Manufacturing Information · 1 item

PROGESTINS CANNOT BE EQUATED AS GROUP WITH PROGESTERONE BECAUSE SOME ARE INHERENTLY ESTROGENIC, SOME SLIGHTLY ANDROGENIC, & SOME PURELY PROGESTATIONAL; CORRESPONDINGLY, THEIR OVULATION-INHIBITING POTENTIALITIES MAY BE MEDIATED IN SOMEWHAT DIFFERENT WAYS. /PROGESTINS/

Applications · 3 items

UsesProgesteron. It was isolated from adrenal glands.

Usesanticoagulant

Uses17α-Hydroxy Progesterone is a metabolite of Progesterone. It was isolated from adrenal glands.

Upstream & downstream products

Upstream raw materials

DiosgeninFormic acidAluminium isopropoxidePotassium hydroxideAcetic anhydridep-Toluenesulfonic acid

Downstream products

6-Dibromomethylene-17-hydroxypregn-4-ene-3,20-dione 17-acetate3,20-Dioxopregn-4-en-17-beta-yl acetateMegestrol acetate17-hydroxy-6-methylenepregn-4-ene-3,20-dione 17-acetateDesoxycorticosterone pivalateCHLORMADINON17alpha-Hydroxypregnenolone17α-Hydroxyprogesterone 3-o-*carboxymeth yloxime5-beta-Dihydro-17-hydroxyprogesterone

Additional notes

DefinitionChEBI: A 17alpha-hydroxy steroid that is the 17alpha-hydroxy derivative of progesterone.